PL EN


Preferences help
enabled [disable] Abstract
Number of results
Journal
2017 | 4 | 4 | 199-209
Article title

Selective laser trabeculoplasty for open angle glaucoma

Content
Title variants
Languages of publication
EN
Abstracts
EN
Selective laser trabeculoplasty (SLT) is an important treatment option in open angle glaucoma. It has been shown to be as effective as argon laser trabeculoplasty in primary open angle glaucoma while having an improved safety profile. Its use is also indicated for other subtypes of open angle glaucoma (OAG) such as pseudoexfoliation (PXE) and pigmentary glaucoma. In this review, we present the current literature on the role of SLT in treating OAG. The indications, duration of effect, repeatability, cost effectiveness and clinical effectiveness of SLT were reviewed. Available evidence comparing SLT with ALT and medical treatment are also presented. We also discuss the applicability of SLT for PXE, pigmentary glaucoma, normal tension glaucoma and advanced OAG. Lastly, the complications of SLT and areas of further research are discussed.
Discipline
Publisher

Journal
Year
Volume
4
Issue
4
Pages
199-209
Physical description
Contributors
author
  • Harrogate and District NHS Foundation Trust, United Kingdom;
author
  • Harrogate and District NHS Foundation Trust, United Kingdom
References
  • 1. Worthen D, Wickham M. Argon laser trabeculotomy. Transactions-American Academy of Ophthalmology and Otolaryngology. American Academy of Ophthalmology and Otolaryngology 1973; 78(2): OP371-375.
  • 2. Wise JB, Witter SL. Argon laser therapy for open-angle glaucoma: a pilot study. Archives of Ophthalmology 1979; 97(2): 319-322.
  • 3. de Moura R, Paranhos CA Jr., Wormald R. Laser trabeculoplasty for open angle glaucoma. Cochrane Database Syst Rev 2007; (4): CD003919.
  • 4. Samples JR, Singh K, Lin SC, et al. Laser trabeculoplasty for open-angle glaucoma: a report by the american academy of ophthalmology. Ophthalmology 2011; 118(11): 2296-2302.
  • 5. Latina MA, Park C. Selective targeting of trabecular meshwork cells: in vitro studies of pulsed and CW laser interactions. Experimental Eye Research 1995; 60(4): 359-371.
  • 6. Latina MA, Sibayan SA, Shin DH, et al. Q-switched 532-nm Nd: YAG laser trabeculoplasty (selective laser trabeculoplasty): A multicenter, pilot, clinical study. Ophthalmology 1998; 105(11): 2082-2090.
  • 7. Kramer TR, Noecker RJ. Comparison of the morphologic changes after selective laser trabeculoplasty and argon laser trabeculoplasty in human eye bank eyes. Ophthalmology 2001; 108(4): 773-779.
  • 8. Alvarado JA, Katz LJ, Trivedi S, Shifera AS. Monocyte modulation of aqueous outflow and recruitment to the trabecular meshwork following selective laser trabeculoplasty. Archives of Ophthalmology 2010; 128(6): 731-737.
  • 9. Bylsma SS, Samples JR, Acott TS, Van Buskik EM. Trabecular cell division after argon laser trabeculoplasty. Archives of Ophthalmology 1988; 106(4): 544-547.
  • 10. Kagan DB, Gorfinkel NS, Hutnik CM. Mechanisms of selective laser trabeculoplasty: a review. Clinical & Experimental Ophthalmology 2014; 42(7): 675-681.
  • 11. Alvarado JA, Iguchi R, Martinez J, et al. Similar effects of selective laser trabeculoplasty and prostaglandin analogs on the permeability of cultured Schlemm canal cells. American Journal of Ophthalmology 2010; 150(2): 254-264.
  • 12. Latina MA, Gulati V. Selective laser trabeculoplasty: stimulating the meshwork to mend its ways. International Ophthalmology Clinics 2004; 44(1): 93-103.
  • 13. Kara N, Altan C, Satana B, et al. Comparison of selective laser trabeculoplasty success in patients treated with either prostaglandin or timolol/dorzolamide fixed combination. Journal of Ocular Pharmacology and Therapeutics 2011; 27(4): 339-342.
  • 14. Ayala M, Chen E. The influence of topical prostaglandin analogues in inflammation after selective laser trabeculoplasty treatment. Journal of Ocular Pharmacology and Therapeutics 2012; 28(2): 118-122.
  • 15. Goldenfeld M, Geyer O, Segev E, et al. Selective laser trabeculoplasty in uncontrolled pseudoexfoliation glaucoma. Ophthalmic Surgery, Lasers and Imaging Retina 2011; 42(5): 390-393.
  • 16. Juzych MS, Chopra V, Banitt MR, et al. Comparison of long-term outcomes of selective laser trabeculoplasty versus argon laser trabeculoplasty in open-angle glaucoma. Ophthalmology 2004; 111(10): 1853-1859.
  • 17. Damji KF, Shah KC, Rock WJ. Selective laser trabeculoplasty vargon laser trabeculoplasty: a prospective randomised clinical trial. British Journal of Ophthalmology 1999; 83(6): 718-722.
  • 18. Tojo N, Oka M, Miyakoshi A, et al. Comparison of fluctuations of intraocular pressure before and after selective laser trabeculoplasty in normal-tension glaucoma patients. Journal of Glaucoma 2014; 23(8): e138-e143.
  • 19. Lee JW, Gangwani RA, Chan JC, Lai JS. Prospective study on the efficacy of treating normal tension glaucoma with a single session of selective laser trabeculoplasty. Journal of Glaucoma 2015; 24(1): 77-80.
  • 20. Bozkurt E, Kara N, Yazici A, et al. Prophylactic selective laser trabeculoplasty in the prevention of intraocular pressure elevation after intravitreal triamcinolone acetonide injection. American Journal of Ophthalmology 2011; 152(6): 976-981.e2.
  • 21. Baykara M, Hamidi NA, Akova-Budak B, et al. Early results of selective laser trabeculoplasty in patients resistant to deep sclerectomy. European Journal of Ophthalmology 2014; 24(3): 371-374.
  • 22. Töteberg-Harms M, Rhee DJ. Selective laser trabeculoplasty following failed combined phacoemulsification cataract extraction and ab interno trabeculectomy. American Journal of Ophthalmology 2013; 156(5): 936-940.e2.
  • 23. Alkin Z, Satana B, Ozkaya A, et al. Selective laser trabeculoplasty for glaucoma secondary to emulsified silicone oil after pars plana vitrectomy: a pilot study. BioMed Research International 2014; 2014.
  • 24. Quigley HA, Broman AT. The number of people with glaucoma worldwide in 2010 and 2020. British Journal of Ophthalmology 2006; 90(3): 262-267.
  • 25. Stein JD, Challa P. Mechanisms of action and efficacy of argon laser trabeculoplasty and selective laser trabeculoplasty. Current Opinion in Ophthalmology 2007; 18(2): 140-145.
  • 26. Pisella P, Pouliquen P, Baudouin C. Prevalence of ocular symptoms and signs with preserved and preservative free glaucoma medication. British Journal of Ophthalmology 2002; 86(4): 418-423.
  • 27. Chawla A, McGalliard JN, Batterbury M. Use of eyedrops in glaucoma: how can we help to reduce non-compliance? Acta Ophthalmologica 2007; 85(4): 464-464.
  • 28. Lichter PR, Musch DC, Gillespie BW, et al. Interim clinical outcomes in the Collaborative Initial Glaucoma Treatment Study comparing initial treatment randomized to medications or surgery. Ophthalmology 2001; 108(11): 1943-1953.
  • 29. Leahy KE, White AJ. Selective laser trabeculoplasty: current perspectives. Clinical Ophthalmology (Auckland, NZ) 2015; 9: 833.
  • 30. Hong BK, et al. Repeat selective laser trabeculoplasty. Journal of Glaucoma 2009; 18(3): 180.
  • 31. Polat J, Grantham L, Mitchel K, Realini T. Repeatability of selective laser trabeculoplasty. British Journal of Ophthalmology 2016; 100(10): 1437-1441.
  • 32. Khouri AS, Lari HB, Berezina TL, et al. Long term efficacy of repeat selective laser trabeculoplasty. Journal of Ophthalmic & Vision Research 2014; 9(4): 444.
  • 33. Francis BA, Loewen N, Hong B, et al. Repeatability of selective laser trabeculoplasty for open-angle glaucoma. BMC Ophthalmology 2016; 16(1): 128.
  • 34. Avery N, Ang GS, Nicholas S, Wells A. Repeatability of primary selective laser trabeculoplasty in patients with primary open-angle glaucoma. International Ophthalmology 2013; 33(5): 501-506.
  • 35. Cantor LB, Katz LJ, Cheng JW, et al. Economic evaluation of medication, laser trabeculoplasty and filtering surgeries in treating patients with glaucoma in the US. Current Medical Research and Opinion 2008; 24(10): 2905-2918.
  • 36. Lee R, Hutnik CM. Projected cost comparison of selective laser trabeculoplasty versus glaucoma medication in the Ontario Health Insurance Plan. Canadian Journal of Ophthalmology/Journal Canadien d'Ophtalmologie 2006; 41(4): 449-456.
  • 37. Group GLTR, The Glaucoma Laser Trial (GLT). 2. Results of argon laser trabeculoplasty versus topical medicines. Ophthalmology 1990; 97(11): 1403-1413.
  • 38. Group GLTR, The Glaucoma Laser Trial (GLT) and glaucoma laser trial follow-up study. 7. Results. American Journal of Ophthalmology 1995; 120(6): 718-731.
  • 39. Leske MC, Heijl A, Hyman L, Bengtsson B. Early manifest glaucoma trial. Ophthalmology 1999; 106(11): 2144-2153.
  • 40. The Advanced Glaucoma Intervention Study (AGIS). 7. The relationship between control of intraocular pressure and visual field deterioration. The AGIS Investigators. Am J Ophthalmol 2000; 130: 429-440.
  • 41. Wong MO, Lee JW, Chay BW, et al. Systematic review and meta-analysis on the efficacy of selective laser trabeculoplasty in open-angle glaucoma. Survey of Ophthalmology 2015; 60(1): 36-50.
  • 42. Martinez-de-la-Casa J, Garcia-Feijoo J, Castillo A, et al. Selective vs argon laser trabeculoplasty: hypotensive efficacy, anterior chamber inflammation, and postoperative pain. Eye 2004; 18(5): 498.
  • 43. Damji KF, Bovell AM, Hodge WG, et al. Selective laser trabeculoplasty versus argon laser trabeculoplasty: results from a 1-year randomised clinical trial. British Journal of Ophthalmology 2006; 90(12): 1490-1494.
  • 44. Birt CM. Selective laser trabeculoplasty retreatment after prior argon laser trabeculoplasty: 1-year results. Canadian Journal of Ophthalmology/Journal Canadien d'Ophtalmologie 2007; 42(5): 715-719.
  • 45. Russo V, Barone A, Cosma A, et al. Selective laser trabeculoplasty versus argon laser trabeculoplasty in patients with uncontrolled open-angle glaucoma. European Journal of Ophthalmology 2009; 19(3): 429.
  • 46. Almeida ED, Moreira Pinto L, Brant Fernandes RA, Prata TS. Pattern of intraocular pressure reduction following laser trabeculoplasty in open-angle glaucoma patients: comparison between selective and nonselective treatment. Clinical Ophthalmology (Auckland, NZ) 2011; 5: 933.
  • 47. Liu Y, Birt CM. Argon versus selective laser trabeculoplasty in younger patients: 2-year results. Journal of Glaucoma 2012; 21(2): 112- -115.
  • 48. Kent SS, Hutnik CM, Birt CM, et al. A randomized clinical trial of selective laser trabeculoplasty versus argon laser trabeculoplasty in patients with pseudoexfoliation. Journal of Glaucoma 2015; 24(5): 344-347.
  • 49. Rosenfeld E, Shemesh G, Kurtz S. The efficacy of selective laser trabeculoplasty versus argon laser trabeculoplasty in pseudophakic glaucoma patients. Clinical Ophthalmology (Auckland, NZ) 2012; 6: 1935.
  • 50. Nagar M, Ogunyomade A, O’Brart DP, et al. A randomised, prospective study comparing selective laser trabeculoplasty with latanoprost for the control of intraocular pressure in ocular hypertension and open angle glaucoma. British Journal of Ophthalmology 2005; 89(11): 1413-1417.
  • 51. Nagar M, Luhishi E, Shah N. Intraocular pressure control and fluctuation: the effect of treatment with selective laser trabeculoplasty. British Journal of Ophthalmology 2009; 93(4): 497-501.
  • 52. Katz LJ, Steinmanna WC, Kabir A, et al. Selective laser trabeculoplasty versus medical therapy as initial treatment of glaucoma: a prospective, randomized trial. Journal of Glaucoma 2012; 21(7): 460-468.
  • 53. Lai JS, Chua J, Tham C, Lam D. Five-year follow up of selective laser trabeculoplasty in Chinese eyes. Clinical & Experimental Ophthalmology 2004; 32(4): 368-372.
  • 54. McIlraith I, Strasfeld M, Colev G, Hutnik CM. Selective laser trabeculoplasty as initial and adjunctive treatment for open-angle glaucoma. Journal of Glaucoma 2006; 15(2): 124-130.
  • 55. Best U, Domack H, Schmidt V. Pressure reduction after selective laser trabeculoplasty with two different laser systems and after argon laser trabeculoplasty – a controlled prospective clinical trial on 284 eyes. Klinische Monatsblatter fur Augenheilkunde 2007; 224(3): 173-179.
  • 56. Schlote T, Kynigopoulos M. Selective laser trabeculoplasty (SLT): 1-year results in early and advanced open angle glaucoma. International Ophthalmology 2016; 36(1): 55-61.
  • 57. Brusini P, Filacorda S. Enhanced Glaucoma Staging System (GSS 2) for classifying functional damage in glaucoma. Journal of Glaucoma 2006; 15(1): 40-46.
  • 58. Law SK, Shih K, Tran DH, et al. Long-term outcomes of repeat vs initial trabeculectomy in open-angle glaucoma. American Journal of Ophthalmology 2009; 148(5): 685-695e1.
  • 59. Suzuki R, Dickens CJ, Iwach AG, et al. Long-term follow-up of initially successful trabeculectomy with 5-fluorouracil injections. Ophthalmology 2002; 109(10): 1921-1924.
  • 60. Landers J, Sarkies N, Bourne R, Watson P. A twenty-year follow-up study of trabeculectomy: risk factors and outcomes. Ophthalmology 2012; 119(4): 694-702.
  • 61. Zhang H, Yang Y, Xu J, Yu M. Selective laser trabeculoplasty in treating post-trabeculectomy advanced primary open-angle glaucoma. Experimental and Therapeutic Medicine 2016; 11(3): 1090-1094.
  • 62. Lee JW, Liu CC, Chan JC, Lai JS. Predictors of success in selective laser trabeculoplasty for primary open angle glaucoma in Chinese. Clinical Ophthalmology (Auckland, NZ) 2014; 8: 1787.
  • 63. Hodge W, Damji KF, Rock W, et al. Baseline IOP predicts selective laser trabeculoplasty success at 1 year post-treatment: results from a randomised clinical trial. British Journal of Ophthalmology 2005; 89(9): 1157-1160.
  • 64. Harasymowycz PJ, Papamatheakis DG, Latina M, et al. Selective laser trabeculoplasty (SLT) complicated by intraocular pressure elevation in eyes with heavily pigmented trabecular meshworks. American Journal of Ophthalmology 2005; 139(6): 1110-1113.
  • 65. Lindegger DJ, Funk J, Jaggi G. Long-term effect of selective laser trabeculoplasty on intraocular pressure in pseudoexfoliation glaucoma. Klinische Monatsblätter für Augenheilkunde 2015; 232(04): 405-408.
  • 66. Ayala M, Chen E. Comparison of selective laser trabeculoplasty (SLT) in primary open angle glaucoma and pseudoexfoliation glaucoma. Clinical Ophthalmology (Auckland, NZ) 2011; 5: 1469.
  • 67. Shazly TA, Smith J, Latina MA. Long-term safety and efficacy of selective laser trabeculoplasty as primary therapy for the treatment of pseudoexfoliation glaucoma compared with primary open-angle glaucoma. Clinical Ophthalmology (Auckland, NZ) 2011; 5: 5.
  • 68. Lee JW, Ho WL, Chan J, Lai J. Efficacy of selective laser trabeculoplasty for normal tension glaucoma: 1 year results. BMC Ophthalmology 2015; 15(1): 1.
  • 69. Lee JW, Shum JJ, Chan JC, Lai JS. Two-year clinical results after selective laser trabeculoplasty for normal tension glaucoma. Medicine 2015; 94(24): e984.
  • 70. Keyser D, Belder D, De Groot V. Prospective study on the effect of selective laser trabeculoplasty in normal tension glaucoma. International Journal of Ophthalmology & Eye Science 2016; S1:008: 36-41.
  • 71. Lee JW, Fu L, Chan J, Lai J. Twenty-four-hour intraocular pressure related changes following adjuvant selective laser trabeculoplasty for normal tension glaucoma. Medicine 2014; 93(27): e238. DOI: 10.1097/MD.0000000000000238.
  • 72. Ayala M. Long-term outcomes of selective laser trabeculoplasty (SLT) treatment in pigmentary glaucoma patients. Journal of Glaucoma 2014; 23(9): 616-619.
  • 73. De Keyser M, De Belder M, De Groot V. Randomized prospective study of the use of anti-inflammatory drops after selective laser trabeculoplasty. Journal of Glaucoma 2017; 26(2): e22-e29.
  • 74. Song J. Complications of selective laser trabeculoplasty: a review. Clinical Ophthalmology (Auckland, NZ) 2016; 10: 137.
  • 75. Koktekir BE, Gedik S, Bakbak B. Bilateral severe anterior uveitis after unilateral selective laser trabeculoplasty. Clinical & Experimental Ophthalmology 2013; 41(3): 305-307.
  • 76. Kim DY, Singh A. Severe iritis and choroidal effusion following selective laser trabeculoplasty. Ophthalmic Surgery, Lasers and Imaging Retina 2008; 39(5): 409-411.
  • 77. Rouhiainen HJ, Teräsvirta ME, Tuovinen EJ. Peripheral anterior synechiae formation after trabeculoplasty. Archives of Ophthalmology 1988; 106(2): 189-191.
  • 78. Shihadeh WA, Ritch R, Liebmann JM. Hyphema occurring during selective laser trabeculoplasty. Ophthalmic Surgery, Lasers and Imaging Retina 2006; 37(5): 432-433.
  • 79. Traverso CE, Greenidge KC, Spaeth GL. Formation of peripheral anterior synechiae following argon laser trabeculoplasty: a prospective study to determine relationship to position of laser burns. Archives of Ophthalmology 1984; 102(6): 861-863.
  • 80. Kitazawa Y, Shirato S, Yamamoto T, Eguchi S. Argon Laser Trabeculoplasty. Variation of Methods and Immediate Complications in Second European Glaucoma Symposium, Helsinki, May 1984. Springer Netherlands1985.
  • 81. Wechsler D, Wechsler I. Cystoid macular oedema after selective laser trabeculoplasty. Eye 2010; 24(6): 1113-1113.
  • 82. Ha JH, Bowling B, Chen SD. Cystoid macular oedema following selective laser trabeculoplasty in a diabetic patient. Clinical & Experimental Ophthalmology 2014; 42(2): 200-201.
  • 83. Wu Z, Huang J, Sadda S. Selective laser trabeculoplasty complicated by cystoid macular edema: report of two cases. Yănkē xuébào 2016; 27(4): 193-197.
  • 84. Klamann MK, Maier AK, Gonnermann J, Ruokonen PC. Adverse effects and short-term results after selective laser trabeculoplasty. Journal of Glaucoma 2014; 23(2): 105-108.
  • 85. Ong K, Ong L, Ong LB. Corneal endothelial abnormalities after selective laser trabeculoplasty (SLT). Journal of Glaucoma 2015; 24(4): 286-290.
  • 86. White AJ, Mukherjee A, Hanspal I, et al. Acute transient corneal endothelial changes following selective laser trabeculoplasty. Clinical & Experimental Ophthalmology 2013; 41(5): 435-441.
  • 87. Regina M, Bunya VY, Orlin SE, Ansari H. Corneal edema and haze after selective laser trabeculoplasty. Journal of Glaucoma 2011; 20(5): 327-329.
  • 88. Song J, Song A, Palmares T, Song M. Myopic Shift Following Selective Laser Trabeculoplasty: A Case Report. British Journal of Medicine & Medical Research 2014; 4(4): 1008-1013.
  • 89. Moubayed SP, Hamid M, Choremis J, Li G. An unusual finding of corneal edema complicating selective laser trabeculoplasty. Canadian Journal of Ophthalmology/Journal Canadien d'Ophtalmologie 2009; 44(3): 337-338.
  • 90. Gazzard G, Konstantakopoulou E, Garway-Heath D, et al. Laser in Glaucoma and Ocular Hypertension (LiGHT) Trial. A multicentre, randomised controlled trial: design and methodology. Br J Ophthalmol. 2017: DOI: 10.1136/bjophthalmol-2017-310877.
  • 91. Pillunat LE, Jungeman AGM, Kimmich F. Micro-invasive glaucoma surgery (MIGS): a review of surgical procedures using stents. Clinical Ophthalmology (Auckland, NZ) 2017; 11: 1583.
Document Type
article
Publication order reference
Identifiers
YADDA identifier
bwmeta1.element.psjd-bfddae88-5ad4-4ccb-86b0-be2f438451f8
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.